Financial Summary (All financials)
| In millions, except per share items | Jan-30-21 | Feb-01-20 | Feb-02-19 | Feb-03-18 | Jan-28-17 | Jan-30-16 | Jan-31-15 | Feb-01-14 |
| Revenues | 2,968.9 | 2,699.2 | 2,865.8 | 2,409.2 | 2,301.0 | 2,602.5 | 3,637.2 | 3,404.4 |
| Revenue growth | 10.0% | -5.8% | 19.0% | 4.7% | -11.6% | -28.4% | 6.8% | 7.4% |
| Cost of goods sold | 1,480.6 | 1,342.2 | 1,407.4 | 947.2 | 1,017.6 | 1,406.1 | 1,799.4 | 1,663.7 |
| Gross profit | 1,488.4 | 1,356.9 | 1,458.4 | 1,461.9 | 1,283.4 | 1,196.4 | 1,837.8 | 1,740.7 |
| Gross margin | 50.1% | 50.3% | 50.9% | 60.7% | 55.8% | 46.0% | 50.5% | 51.1% |
| Sales and marketing | 467.2 | 464.6 | 424.4 | 238.2 | 251.2 | 279.2 | 139.6 | 151.9 |
| Research and development | 1,072.7 | 1,080.4 | 914.0 | 714.4 | 805.0 | 954.7 | 1,091.5 | 1,154.0 |
| General and administrative | | | | | | | 124.0 | 105.4 |
| EBITA | 221.2 | 124.7 | 226.6 | 507.7 | 141.0 | -90.7 | 477.3 | 331.0 |
| EBITA margin | 7.5% | 4.6% | 7.9% | 21.1% | 6.1% | -3.5% | 13.1% | 9.7% |
| Amortization of intangibles | 443.6 | 368.1 | 183.3 | 3.6 | 10.6 | | 15.7 | 43.9 |
| EBIT | -222.4 | -243.4 | 43.3 | 504.1 | 130.4 | -90.7 | 461.5 | 287.1 |
| EBIT margin | -7.5% | -9.0% | 1.5% | 20.9% | 5.7% | -3.5% | 12.7% | 8.4% |
| Pre-tax income | -322.2 | 798.4 | -4.6 | 451.2 | 147.4 | -727.7 | 479.7 | 306.3 |
| Income taxes | -44.9 | -786.0 | 174.4 | 18.1 | 72.6 | 10.7 | -4.1 | -9.1 |
| Tax rate | 13.9% | | | 4.0% | 49.2% | | | |
| Earnings from continuing ops | -277.3 | 1,584.4 | -179.1 | 433.1 | 74.8 | -738.4 | 483.8 | 315.3 |
| Earnings from discontinued ops | | | | 0.0 | | | | |
| Net income | -277.3 | 1,584.4 | -179.1 | 520.8 | 21.2 | -811.4 | 435.3 | 315.3 |
| Net margin | -9.3% | 58.7% | -6.2% | 21.6% | 0.9% | -31.2% | 12.0% | 9.3% |
| |
| Diluted EPS | ($0.41) | $2.34 | ($0.30) | $0.85 | $0.14 | ($1.45) | $0.93 | $0.63 |
| Shares outstanding (diluted) | 668.8 | 676.1 | 591.2 | 509.7 | 517.5 | 510.9 | 520.8 | 504.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|